BiotechTube
Home/Aldeyra Therapeutics/Joshua Reed
JR

Joshua Reed

Chief Financial Officer & Treasurer

Aldeyra Therapeutics

Therapeutic Areas

OphthalmologyImmunology

Aldeyra Therapeutics Pipeline

DrugIndicationPhase
ReproxalapDry Eye DiseaseNDA Submitted
ADX-2191Primary Vitreoretinal LymphomaPhase 3
ADX-629Systemic Immune-Mediated DiseasesPhase 2a

Leadership Team at Aldeyra Therapeutics

TC
Todd C. Brady
President, CEO & Chairman
DJ
David J. Clark
Chief Medical Officer
SG
Stephen G. Machatha
Chief Development Officer
BH
Ben H. McGraw III
Chief Commercial Officer
View full Aldeyra Therapeutics profile